Kenneth Douglas

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies

Christoph Licht, Larry A. Greenbaum, Petra Muus et al. · Kidney International · 2015 · 415 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +17

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

Julia Scarisbrick, Peter C. Taylor, Udo Holtick et al. · British Journal of Dermatology · 2008 · 174 citations

Medicine, Hematology, Oncology +13

The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society

Arun Alfred, Peter C. Taylor, Fiona L. Dignan et al. · British Journal of Haematology · 2017 · 137 citations · Full text

Medicine, Hematology, Immunology +16

The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF

Alessandra D’Addio, Antonio Curti, Nina Worel et al. · Bone Marrow Transplantation · 2010 · 88 citations

Medicine, Oncology, Chemotherapy +10

Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products

Catherine Howell, Kenneth Douglas, G. Cho et al. · Transfusion Medicine · 2015 · 69 citations · Full text

Medicine, Hematology, Cell Therapy +15